Sort evidence by development stage
Categorize evidence types by the drug-development stage they most directly support.
Place each evidence card in the FDA drug-development stage it most directly supports. Discovery Preclinical Clinical FDA Review Post-Market Target knockdown and pathway rescue in patient-derived cells GLP toxicology package supporting first-in-human dose rationale Phase 1 dose escalation with tolerability and pharmacokinetics Integrated quality, nonclinical, and clinical dossier under regulatory review Adverse event trend after launch across broader patient use Animal model efficacy used to decide whether human testing is plausible Approved label update based on new safety information Mechanism-of-action hypothesis for a novel cytokine target
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in